federal_register: E8-18094
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E8-18094 | Implantation or Injectable Dosage Form New Animal Drugs; Ceftiofur Hydrochloride | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia and Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of a ceftiofur hydrochloride injectable suspension for treatment of various bacterial infections in swine and cattle. | 2008-08-06 | 2008 | 8 | https://www.federalregister.gov/documents/2008/08/06/E8-18094/implantation-or-injectable-dosage-form-new-animal-drugs-ceftiofur-hydrochloride | https://www.govinfo.gov/content/pkg/FR-2008-08-06/pdf/E8-18094.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia and Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription... |